Eli Lilly: Ebglyss To Challenge Dupixent In Atopic Dermatitis
Eli Lilly's Ebglyss gains FDA approval for atopic dermatitis treatment, poised to rival Dupixent with strong performance in ...
Eli Lilly & Co: Strong Buy Rating Amid Robust Product Growth and Promising Pipeline
Analyst Chris Schott from J.P. Morgan maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and keeping the price target ...
Reuters15h
United States
The man charged with attempting to assassinate Donald Trump after allegedly positioning himself with a rifle outside one of the former president's Florida golf courses on Sept. 15 pleaded not ...
Associated Press8h
U.S. News
Copyright 2024 The Associated Press. All Rights Reserved. People across the American Southeast stay resilient in the wake of Hurricane Helene Americans in the ...